The U.S. dental bone graft substitute (DBGS) and biomaterials market was valued at $650 million in 2024 and is projected to grow at a CAGR of 6.8%, reaching over $1.0 billion by 2031.
Market growth is driven by:
- Advancements in regenerative dental treatments.
- Increasing demand for dental implants and periodontal procedures.
- Growing adoption of dental biomaterials for tissue regeneration.
The 2025 report suite covers:
- Dental Bone Graft Substitutes
- Dental Growth Factors
- Dental Barrier Membranes
- Local Antimicrobial Periodontal Treatments
- Dental Soft Tissue Regeneration
Collectively, these segments make up the dental biomaterials market.
Market Report Data Types Included
- Unit Sales & Average Selling Prices (ASP)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Company Profiles & Product Portfolios
- Leading Competitors
U.S. Dental Bone Graft Substitute Market Trends
Limited Insurance Coverage Restricts Market Growth:
- Most dental insurance plans do not cover implant and bone grafting procedures, leading to high out-of-pocket costs for patients.
- Economic disparities limit access to advanced periodontal treatments.
- Expanding insurance coverage could significantly increase procedural volume and drive market demand.
Market Growth Linked to Dental Implant Demand:
- Bone graft substitutes are widely used in dental implant procedures.
- As dental implant adoption rises, so does demand for regenerative materials.
U.S. Dental Bone Graft Substitute Market Share Insights (2024)
1 Geistlich - Market Leader
- Dominant player in the DBGS and biomaterials market.
- Strong presence in the dental bone graft substitute, dental barrier membrane, and soft tissue regeneration segments.
- Key products include Bio-Oss®, Bio-Gide®, and Mucograft®.
- Acquisition of Lynch Biologics in 2022 expanded its portfolio with GEM 21S®, reinforcing its leadership in dental growth factors.
2 ZimVie - Second-Largest Competitor
- Broad portfolio across multiple dental biomaterial segments.
- Key products include Puros® Allograft, Regeneross® line, and IngeniOs® synthetics.
- Offers high-quality alternatives competing with top DBGS brands.
3 OraPharma - Third-Largest Competitor
- Leader in the local antimicrobial periodontal treatment segment.
- Flagship product ARESTIN® (minocycline HCl) Microspheres, 1 mg enhances periodontal treatment effectiveness.
- Strong presence in periodontal disease management.
Market Segmentation Summary
Dental Bone Graft Substitute Market - Further segmented into:
- Mineralized Allograft
- Demineralized Bone Matrix (DMB) Allograft
- Xenograft
- Synthetics
Dental Growth Factor Market - Further segmented into:
- Emdogain
- GEM 21S®
- Infuse
- Osteocel®
Dental Barrier Membrane Market - Further segmented into:
- Resorbable Membranes
- Non-Resorbable Membranes
- Local Antimicrobial Periodontal Treatment Market
Dental Soft Tissue Regeneration Market - Further segmented into:
- Regeneration
- Wound Care
Research Scope Summary
- Regions Covered
- United States
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size & Growth Rates
- Procedure Numbers
- Unit Sales & ASP
- Market Shares & Forecasts through 2031
Qualitative Coverage
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls & Regulatory Developments
- Disruptive Technologies & Emerging Innovations
- Disease Overviews
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- Internal Database
Table of Contents
1. Executive summary
2. U.S. Dental Bone Graft Substitute and Other Biomaterials Market Overview
3. DENTAL BONE GRAFT SUBSTITUTE Market
4. Dental Growth Factor Market
5. DENTAL Barrier Membrane Market
6. local Antimicrobial Periodontal Treatment Market
7. Dental Soft Tissue Regeneration Market
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Dental
- Inion
- AbbVie
- Kerr
- ACE SOUTHERN
- Keystone Dental
- Benco
- Klockner
- Bicon
- LifeNet Health
- BioHorizons
- Lynch Biologics
- BioMimetic
- Medtronic
- Botiss Biomaterials
- MegaGen
- Citagenix
- Neodent
- Collagen Matrix
- Neoss
- Curasan
- Nobel Biocare
- Datum Dental
- OCO Biomedical
- Dentium USA
- OraPharma
- Dentsply Sirona
- Osteogenic Biomedical
- Dexcel Pharma
- Osteohealth
- Dyna Dental
- Patterson
- Envista
- Salvin
- Geistlich
- Snoasis Medical
- Glidewell Dental
- Straumann Group
- Halma
- Thommen Medical
- Henry Schein
- Tissue Banks
- Hiossen
- Unicare Biomedical
- Impladent
- ZimVie
- Implant Direct
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 174 |
Published | March 2025 |
Forecast Period | 2024 - 2031 |
Estimated Market Value ( USD | $ 650 Million |
Forecasted Market Value ( USD | $ 1000 Million |
Compound Annual Growth Rate | 6.8% |
Regions Covered | United States |